Page last updated: 2024-08-21

quinazolines and marimastat

quinazolines has been researched along with marimastat in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuoka, M	1
Yamada, K; Yamaguchi, S; Yamamura, T	1
Cartee, TV; Pollack, BP; Sapkota, B	1
Harder, J; Mildner, M; Rademacher, F; Schröder, L; Simanski, M	1

Reviews

2 review(s) available for quinazolines and marimastat

Article	Year
[Progress in diagnosis and treatment of lung cancer]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2002, Mar-20, Volume: 91 Suppl Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Endothelial Growth Factors; Enzyme Inhibitors; Gefitinib; Genetic Therapy; Humans; Hydroxamic Acids; Lung Neoplasms; Lymphokines; Mass Screening; Metalloendopeptidases; Quinazolines; Receptor Protein-Tyrosine Kinases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
[Angiogenesis and metastasis in colorectal cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7 Topics: Angiopoietin-1; Angiopoietin-2; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Colorectal Neoplasms; Enzyme Inhibitors; Gefitinib; Humans; Hydroxamic Acids; Metalloendopeptidases; Neoplasm Metastasis; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Quinazolines; Vascular Endothelial Growth Factor A	2003

Article

Year

[Progress in diagnosis and treatment of lung cancer].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2002, Mar-20, Volume: 91 Suppl

Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Endothelial Growth Factors; Enzyme Inhibitors; Gefitinib; Genetic Therapy; Humans; Hydroxamic Acids; Lung Neoplasms; Lymphokines; Mass Screening; Metalloendopeptidases; Quinazolines; Receptor Protein-Tyrosine Kinases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

[Angiogenesis and metastasis in colorectal cancer].

Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7

Topics: Angiopoietin-1; Angiopoietin-2; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Colorectal Neoplasms; Enzyme Inhibitors; Gefitinib; Humans; Hydroxamic Acids; Metalloendopeptidases; Neoplasm Metastasis; Neovascularization, Pathologic; Protein-Tyrosine Kinases; Quinazolines; Vascular Endothelial Growth Factor A

2003

Other Studies

2 other study(ies) available for quinazolines and marimastat

Article	Year
Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13 Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line; Cell Line, Tumor; Cetuximab; ErbB Receptors; Gene Expression Regulation; HCT116 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Hydroxamic Acids; Immunologic Factors; Interferon-gamma; Keratinocytes; Models, Biological; Nuclear Proteins; Protein Kinase Inhibitors; Quinazolines; Skin; Trans-Activators	2011
The role of RNase 7 in innate cutaneous defense against Pseudomonas aeruginosa. Experimental dermatology, 2017, Volume: 26, Issue:3 Topics: ADAM17 Protein; Antibodies, Neutralizing; Cells, Cultured; Cetuximab; Epidermis; ErbB Receptors; Gene Expression; Gene Silencing; Humans; Hydroxamic Acids; Keratinocytes; Organoids; Pseudomonas aeruginosa; Quinazolines; Ribonucleases; RNA, Small Interfering; Signal Transduction; Skin; Toll-Like Receptor 5; Tyrphostins	2017

Article

Year

Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13

Topics: Antibodies, Blocking; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line; Cell Line, Tumor; Cetuximab; ErbB Receptors; Gene Expression Regulation; HCT116 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Hydroxamic Acids; Immunologic Factors; Interferon-gamma; Keratinocytes; Models, Biological; Nuclear Proteins; Protein Kinase Inhibitors; Quinazolines; Skin; Trans-Activators

2011

The role of RNase 7 in innate cutaneous defense against Pseudomonas aeruginosa.

Experimental dermatology, 2017, Volume: 26, Issue:3

Topics: ADAM17 Protein; Antibodies, Neutralizing; Cells, Cultured; Cetuximab; Epidermis; ErbB Receptors; Gene Expression; Gene Silencing; Humans; Hydroxamic Acids; Keratinocytes; Organoids; Pseudomonas aeruginosa; Quinazolines; Ribonucleases; RNA, Small Interfering; Signal Transduction; Skin; Toll-Like Receptor 5; Tyrphostins

2017